Terms: = Breast cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Treatment
469 results:
1. Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies.
Godinez Paredes JM; Rodriguez I; Ren M; Orozco A; Ortiz J; Albanez A; Jones C; Nahleh Z; Barreda L; Garland L; Torres-Gonzalez E; Wu D; Luo W; Liu J; Argueta V; Orozco R; Gharzouzi E; Dean M
Breast Cancer Res Treat; 2024 Jun; 205(3):567-577. PubMed ID: 38520597
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
3. A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate cancer Demonstrating "BRCAness" Genotype (ROAR).
Sahu KK; Li H; Mathew Thomas V; Benson M; Boucher K; Gupta S; Kohli M; Swami U; Agarwal N; Maughan BL
Oncologist; 2024 May; 29(5):450-e725. PubMed ID: 38452035
[TBL] [Abstract] [Full Text] [Related]
4. Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
[TBL] [Abstract] [Full Text] [Related]
5. Immediate prepectoral breast reconstruction in nipple-sparing mastectomy with Wise-pattern incision in large and ptotic breasts: Our experience and short-term results.
Antoniazzi E; De Grazia A; Dell'Antonia F; Pasquali S; Burelli P; Rizzetto C; Berna G
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():154-163. PubMed ID: 38412604
[TBL] [Abstract] [Full Text] [Related]
6. 21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal breast cancer after breast-conserving surgery.
Xie SJ; Wang RJ; Wu SG; Zhang FX
Breast; 2024 Apr; 74():103679. PubMed ID: 38367283
[TBL] [Abstract] [Full Text] [Related]
7. A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic
Tahara M; Kiyota N; Imai H; Takahashi S; Nishiyama A; Tamura S; Shimizu Y; Kadowaki S; Ito KI; Toyoshima M; Hirashima Y; Ueno S; Sugitani I
Thyroid; 2024 Apr; 34(4):467-476. PubMed ID: 38343359
[No Abstract] [Full Text] [Related]
8. Inhibition of atm promotes PD-L1 expression by activating JNK/c-Jun/TNF-α signaling axis in triple-negative breast cancer.
Liu C; Qian X; Yu C; Xia X; Li J; Li Y; Xie Y; Gao G; Song Y; Zhang M; Xue H; Wang X; Sun H; Liu J; Deng W; Guo X
Cancer Lett; 2024 Apr; 586():216642. PubMed ID: 38278470
[TBL] [Abstract] [Full Text] [Related]
9. Investigation of Genetic Alterations Associated With Interval breast cancer.
Rodriguez J; Grassmann F; Xiao Q; Eriksson M; Mao X; Bajalica-Lagercrantz S; Hall P; Czene K
JAMA Oncol; 2024 Mar; 10(3):372-379. PubMed ID: 38270937
[TBL] [Abstract] [Full Text] [Related]
10. Radiation-Induced Lymphopoenia and Treatment Outcome in Hereditary breast cancer Patients.
Argalácsová S; Křížová Ľ; Matějů M; Svobodová D; Vočka M
Folia Biol (Praha); 2023; 69(3):91-98. PubMed ID: 38206774
[TBL] [Abstract] [Full Text] [Related]
11. Effect of bisphosphonates and statins on the in vitro radiosensitivity of breast cancer cell lines.
Bodgi L; Bou-Gharios J; Azzi J; Challita R; Feghaly C; Baalbaki K; Kharroubi H; Chhade F; Geara F; Abou-Kheir W; Ayoub Z
Pharmacol Rep; 2024 Feb; 76(1):171-184. PubMed ID: 38151641
[TBL] [Abstract] [Full Text] [Related]
12. Germline testing of
Woodward ER; Lalloo F; Forde C; Pugh S; Burghel GJ; Schlecht H; Harkness EF; Howell A; Howell SJ; Gandhi A; Evans DG
J Med Genet; 2024 Mar; 61(4):385-391. PubMed ID: 38123987
[TBL] [Abstract] [Full Text] [Related]
13. A real-world data analysis-based study of Chinese medicine treatment patterns after breast cancer surgery.
Hu L; Yang Y; Wang Z; Wen C; Cheng X
Medicine (Baltimore); 2023 Dec; 102(50):e36642. PubMed ID: 38115283
[TBL] [Abstract] [Full Text] [Related]
14. PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated breast/Ovarian cancer.
Ghosh M; Kang MS; Katuwal NB; Hong SD; Jeong YG; Park SM; Kim SG; Moon YW
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069409
[TBL] [Abstract] [Full Text] [Related]
15. The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
Toda S; Iwasaki H; Okubo Y; Hayashi H; Kadoya M; Takahashi H; Yokose T; Hiroshima Y; Masudo K
Endocr J; 2024 Jan; 71(1):31-37. PubMed ID: 38044137
[TBL] [Abstract] [Full Text] [Related]
16. Trastuzumab Resistance in Patients With HER2-Positive Advanced breast cancer: Results From the SONABRE Registry.
Ibragimova KIE; Geurts SME; Laczkó D; Meegdes M; Erdkamp F; Heijns JB; Tol J; Vriens BEPJ; Aaldering KNA; Dercksen MW; Pepels MJAE; Peters NAJB; van de Winkel LMH; van de Wouw AJ; de Fallois A; van Kats MACE; Tjan-Heijnen VCG
Clin Breast Cancer; 2024 Feb; 24(2):103-111. PubMed ID: 38007349
[TBL] [Abstract] [Full Text] [Related]
17. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
[TBL] [Abstract] [Full Text] [Related]
18. breast cancer cells are sensitized by piperine to radiotherapy through estrogen receptor-α mediated modulation of a key NHEJ repair protein- DNA-PK.
Shaheer K; Prabhu BS; Ali HS; Lakshmanan-M D
Phytomedicine; 2024 Jan; 122():155126. PubMed ID: 37913642
[TBL] [Abstract] [Full Text] [Related]
19. Deep learning based MLC aperture and monitor unit prediction as a warm start for breast VMAT optimisation.
Vandewinckele L; Reynders T; Weltens C; Maes F; Crijns W
Phys Med Biol; 2023 Nov; 68(22):. PubMed ID: 37903442
[No Abstract] [Full Text] [Related]
20. PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.
Carter J; Hulse M; Sivakumar M; Burtell J; Thodima V; Wang M; Agarwal A; Vykuntam K; Spruance J; Bhagwat N; Rager J; Ruggeri B; Scherle P; Ito K
Cancer Res Commun; 2023 Nov; 3(11):2233-2243. PubMed ID: 37861290
[TBL] [Abstract] [Full Text] [Related]
[Next]
